University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
INTRODUCTION
ABIM MOC Activity ID
1/26/2021 - Medical Grand Rounds: Pulmonary Hypertension Year in Review
QUIZ
EVALUATION
CERTIFICATE
Credit Hours: CME 1.25
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Improve therapeutic skills for the use of Nocturnal Oxygen in Chronic Obstructive Pulmonary Patients.
- Follow new pharmacologic treatments for excessive daytime sleepiness in Obstructive Sleep Apnea.
- Improve therapeutic skill for management of chronic insomnia using behavioral therapy
- Review COVID19 molecular and imaging diagnosis
- Explain different modalities to provide respiratory support in patients with COVID19
- Describe host-response therapeutics for COVID19
- Describe a new treatment for hypereosinophilic syndrome
- Analyze the efficacy of omalizumab in treatment of nasal polyposis
- Assess the efficacy of dupilumab in treatment of nasal polyposis
- Review the recommended guidelines for pulmonary arterial hypertension diagnosis and treatment
- Explain new therapeutics in pulmonary arterial hypertension
Suggested additional reading:
- Lacasse, Yves et al. “Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease.” The New England journal of medicine vol. 383,12 (2020): 1129-1138. doi:10.1056/NEJMoa2013219.
- Dauvilliers, Yves et al. “Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.” American journal of respiratory and critical care medicine vol. 201,9 (2020): 1135-1145. doi:10.1164/rccm.201907-1284OC.
- Morin, Charles M et al. “Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial.” JAMA psychiatry, vol. 77,11 1–9. 8 Jul. 2020
- RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. 2020 Jul 17:NEJMoa2021436. doi: 10.1056/NEJMoa2021436.
- The REMAP-CAP investigators. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report. MedRxiv.
- Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232. doi:10.1016/S0140-6736(20)32656-8. PMID: 33428867.
- Shomali, W., & Gotlib, J. (2019). World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. American journal of hematology, 94(10), 1149-1167.
- Kim, Christine, et al. "Role of biologics in chronic rhinosinusitis with nasal polyposis: state of the art review." Otolaryngology–Head and Neck Surgery (2020)
- Anderson III, William C., and Stanley J. Szefler. "Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: to biologic or not to biologic?." Annals of Allergy, Asthma & Immunology 122.4 (2019): 367-372.
- Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 Jan 24;53(1):1801913.
- Galiè N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019 Jan 24;53(1):1801889.
- Galiè N, Barberà JA, Frost AE, et al; AMBITION Investigators. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015 Aug 27;373(9):834-44.
Joint Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Dr. Petrov is a consultant with CSL Behring, Takeda, and Pharming.
No relationships with industry relevant to the content of this educational activity have been disclosed.
Dr. Kitsios receives grant/research funds from Karius, Inc.
No relationships with industry relevant to the content of this educational activity have been disclosed.
The University of Pittsburgh is an affirmative action, equal opportunity institution.